FDA grants approval for expanded use of Zykadia in first-line ALK-positive metastatic NSCLC May 29, 2017 No Comments
FDA grants accelerated approval to Keytruda and priority review for further indication May 24, 2017 No Comments
FDA approves Keytruda for certain patients with locally advanced or metastatic urothelial carcinoma May 19, 2017 No Comments
European Commission approves dinutuximab beta for the treatment of high-risk neuroblastoma May 11, 2017 No Comments
RSS